Comparison of ARIMA model and XGBoost model for prediction of human brucellosis in mainland China: a time-series study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
07 12 2020
Historique:
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 26 3 2021
Statut: epublish

Résumé

Human brucellosis is a public health problem endangering health and property in China. Predicting the trend and the seasonality of human brucellosis is of great significance for its prevention. In this study, a comparison between the autoregressive integrated moving average (ARIMA) model and the eXtreme Gradient Boosting (XGBoost) model was conducted to determine which was more suitable for predicting the occurrence of brucellosis in mainland China. Time-series study. Mainland China. Data on human brucellosis in mainland China were provided by the National Health and Family Planning Commission of China. The data were divided into a training set and a test set. The training set was composed of the monthly incidence of human brucellosis in mainland China from January 2008 to June 2018, and the test set was composed of the monthly incidence from July 2018 to June 2019. The mean absolute error (MAE), root mean square error (RMSE) and mean absolute percentage error (MAPE) were used to evaluate the effects of model fitting and prediction. The number of human brucellosis patients in mainland China increased from 30 002 in 2008 to 40 328 in 2018. There was an increasing trend and obvious seasonal distribution in the original time series. For the training set, the MAE, RSME and MAPE of the ARIMA(0,1,1)×(0,1,1) The performance of the XGBoost model was better than that of the ARIMA model. The XGBoost model is more suitable for prediction cases of human brucellosis in mainland China.

Identifiants

pubmed: 33293308
pii: bmjopen-2020-039676
doi: 10.1136/bmjopen-2020-039676
pmc: PMC7722837
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e039676

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Malar J. 2016 Nov 22;15(1):566
pubmed: 27876041
Biomed Res Int. 2016;2016:5103718
pubmed: 27872852
Sci Rep. 2016 Aug 31;6:32367
pubmed: 27577101
Am J Trop Med Hyg. 2015 Oct;93(4):757-60
pubmed: 26149866
BMC Vet Res. 2018 Dec 12;14(1):393
pubmed: 30541567
BMJ Open. 2014 Apr 08;4(4):e004470
pubmed: 24713215
BMC Infect Dis. 2016 Dec 19;16(1):760
pubmed: 27993134
Eur J Cardiothorac Surg. 2020 Feb 1;57(2):350-358
pubmed: 31280308
Can J Infect Dis Med Microbiol. 2019 Jun 13;2019:1429462
pubmed: 31312278
BMC Infect Dis. 2013 Nov 01;13:514
pubmed: 24176041
PLoS One. 2018 Nov 26;13(11):e0205500
pubmed: 30476930
BMC Genomics. 2018 May 23;19(1):390
pubmed: 29792182
BMJ Open. 2016 Oct 17;6(10):e011038
pubmed: 27797981
Environ Health Prev Med. 2018 Jun 19;23(1):23
pubmed: 29921215
Sci Rep. 2018 Nov 19;8(1):16977
pubmed: 30451894
Biomed Res Int. 2018 Apr 22;2018:5712920
pubmed: 29850535
PLoS One. 2020 May 12;15(5):e0232910
pubmed: 32396582
Open Forum Infect Dis. 2017 Nov 01;4(4):ofx237
pubmed: 29255733
BMC Infect Dis. 2019 May 14;19(1):414
pubmed: 31088391
Infect Drug Resist. 2019 Apr 29;12:1011-1020
pubmed: 31118707
BMC Public Health. 2020 Apr 16;20(1):506
pubmed: 32299414
BMC Infect Dis. 2019 Feb 28;19(1):201
pubmed: 30819243
PLoS Negl Trop Dis. 2019 May 2;13(5):e0007366
pubmed: 31048848
Front Genet. 2019 Nov 12;10:1077
pubmed: 31781160
Int J Environ Res Public Health. 2017 Mar 12;14(3):
pubmed: 28287496
J Res Health Sci. 2019 Dec 04;19(4):e00462
pubmed: 32291361
Adv Physiol Educ. 2018 Jun 1;42(2):343-347
pubmed: 29761718
PLoS One. 2014 Nov 11;9(11):e108592
pubmed: 25386963
J Orthop Surg Res. 2018 Sep 4;13(1):222
pubmed: 30180854
Sci Rep. 2018 Oct 26;8(1):15901
pubmed: 30367079
Zoonoses Public Health. 2019 Nov;66(7):759-772
pubmed: 31305019
PLoS One. 2015 Aug 13;10(8):e0135492
pubmed: 26270814
BMC Med Inform Decis Mak. 2019 Nov 6;19(1):211
pubmed: 31694707
Infect Drug Resist. 2019 Jun 06;12:1565-1571
pubmed: 31239732
J Transl Med. 2019 Jan 23;17(1):38
pubmed: 30674317
Infect Drug Resist. 2019 Jul 26;12:2311-2322
pubmed: 31440067
Molecules. 2016 Jul 28;21(8):
pubmed: 27483216
PLoS One. 2018 Apr 19;13(4):e0195875
pubmed: 29672639
BMC Infect Dis. 2016 Feb 06;16:69
pubmed: 26852019
Int J Infect Dis. 2018 Sep;74:61-70
pubmed: 29990540
BMC Syst Biol. 2018 Nov 22;12(Suppl 6):105
pubmed: 30463545
BMC Infect Dis. 2015 Feb 03;15:36
pubmed: 25644986
Infect Ecol Epidemiol. 2018 Jul 24;8(1):1500846
pubmed: 30083304
PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2779
pubmed: 24763320

Auteurs

Mirxat Alim (M)

Department of Epidemiology, China Medical University, Shenyang, China.

Guo-Hua Ye (GH)

Department of Epidemiology, China Medical University, Shenyang, China.

Peng Guan (P)

Department of Epidemiology, China Medical University, Shenyang, China.

De-Sheng Huang (DS)

Department of Mathematics, China Medical University, Shenyang, China.

Bao-Sen Zhou (BS)

Department of Epidemiology, China Medical University, Shenyang, China.

Wei Wu (W)

Department of Epidemiology, China Medical University, Shenyang, China wuwei@cmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH